This inventor holds 1 USPTO granted patent. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jieli Wei: Innovator in Bi-functional Compounds
Introduction
Jieli Wei is a notable inventor based in Kunming, China. He has made significant contributions to the field of bi-functional compounds, particularly in the context of medical treatments. His work focuses on innovative methods that can potentially improve therapeutic outcomes for various diseases.
Latest Patents
Jieli Wei holds a patent for "Mitogen-activated protein kinase kinase (MEK) degradation compounds and methods of use." This patent relates to heterobifunctional compounds, which are bi-functional small molecule compounds. The disclosure includes compositions comprising these compounds and methods for their use in treating specific diseases in subjects in need. Additionally, it outlines methods for identifying such heterobifunctional compounds.
Career Highlights
Jieli Wei is affiliated with the Icahn School of Medicine at Mount Sinai, where he continues to advance his research in the field of biochemistry and pharmacology. His work has the potential to lead to groundbreaking treatments that could benefit many patients.
Collaborations
Some of Jieli Wei's coworkers include Jian Jin and Jing Liu, who contribute to his research endeavors and collaborative projects.
Conclusion
Jieli Wei's innovative work in the development of heterobifunctional compounds showcases his commitment to advancing medical science. His contributions are paving the way for new therapeutic strategies that could significantly impact patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile